Descrizione Clinica
Stomach and Intestine Mylicongas 50cpr mast 40mg Mylicon
MYLICONGAS 40 MG COMPRESSE MASTICAL
active ingredients
Each tablet contains: Active ingredient: symeticons (dimethylpoxane activated) mg 40 For the complete list of excipients, see 6.1Excellent
Saccarina; Alginic acid; Lactose; Sodium bicarbonate; Povidone; Synlicate calcium idrate; Magnesium stearateTherapeutic indications
Syntomatic treatment of gastro-enteric meteorism, and adult aerophagia.Contraindications
Hypersensitivity to the active ingredient or any of the excipients. Generally contraindicated in pregnancy (see paragraph 4.6).Population
Adults: 4 tablets daily (2 at the end of each main meal). Tablets must be chewed.Conservation
Store the medicine in the original packaging to repair the product from light and moistureWarnings
Do not exceed the recommended doses. After a short period of treatment without appreciable results consult your doctor. The drug contains lactose is therefore not suitable for individuals with lactase deficiency, galactemia or glucose/galactose disease syndrome.Interactions
They are not known, nor have they been reported, incompatibility with other drugs.Effects
No side effects of MYLICONGAS have been highlighted.Overdosing
Overdose phenomena have not been reported with the use of MYLICONGAS. Pregnancy.
There is no adequate data on the use of MYLICONGAS in pregnant women, so it should not be used in pregnancy unless a real need and after risk/benefit assessment by the doctor. Nursing.
It is not known whether symeticons are excreted in breast milk. The excretion of symeticons in breast milk was not studied in animals. The decision whether to continue/interrupt breastfeeding or continue/interrupts treatment based on semeticons should be taken taking into account the benefit of breastfeeding for the newborn and the treatment based on simeticons for women.
Source: Farmadati
